First Header Logo Second Header Logo

Connection

Karl-Erik Andersson to Urinary Bladder, Neurogenic

This is a "connection" page, showing publications Karl-Erik Andersson has written about Urinary Bladder, Neurogenic.
  1. Andersson KE. Potential Future Pharmacological Treatment of Bladder Dysfunction. Basic Clin Pharmacol Toxicol. 2016 Oct; 119 Suppl 3:75-85.
    View in: PubMed
    Score: 0.476
  2. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Mechanisms of action of botulinum neurotoxins, ß3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012 Mar; 31(3):300-8.
    View in: PubMed
    Score: 0.356
  3. Soler R, Füllhase C, Santos C, Andersson KE. Development of bladder dysfunction in a rat model of dopaminergic brain lesion. Neurourol Urodyn. 2011 Jan; 30(1):188-93.
    View in: PubMed
    Score: 0.319
  4. Eberli D, Horst M, Mortezavi A, Andersson KE, Gobet R, Sulser T, Simon HU, Salemi S. Increased autophagy contributes to impaired smooth muscle function in neurogenic lower urinary tract dysfunction. Neurourol Urodyn. 2018 11; 37(8):2414-2424.
    View in: PubMed
    Score: 0.138
  5. Horst M, Heutschi J, van den Brand R, Andersson KE, Gobet R, Sulser T, Courtine G, Eberli D. Multisystem neuroprosthetic training improves bladder function after severe spinal cord injury. J Urol. 2013 Feb; 189(2):747-53.
    View in: PubMed
    Score: 0.093
  6. Hipp JA, Hipp JD, Yoo JJ, Atala A, Andersson KE. Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int. 2008 Sep; 102(6):741-6.
    View in: PubMed
    Score: 0.068
  7. Andersson KE. Tachykinins: role in detrusor overactivity? Eur Urol. 2006 Mar; 49(3):423-5.
    View in: PubMed
    Score: 0.058
  8. Drake MJ, Hedlund P, Andersson KE, Brading AF, Hussain I, Fowler C, Landon DN. Morphology, phenotype and ultrastructure of fibroblastic cells from normal and neuropathic human detrusor: absence of myofibroblast characteristics. J Urol. 2003 Apr; 169(4):1573-6.
    View in: PubMed
    Score: 0.048
  9. Kaidoh K, Igawa Y, Takeda H, Yamazaki Y, Akahane S, Miyata H, Ajisawa Y, Nishizawa O, Andersson KE. Effects of selective beta2 and beta3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol. 2002 Sep; 168(3):1247-52.
    View in: PubMed
    Score: 0.046
  10. Colaco M, Osman NI, Karakeçi A, Artibani W, Andersson KE, Badlani GH. Current concepts of the acontractile bladder. BJU Int. 2018 08; 122(2):195-202.
    View in: PubMed
    Score: 0.034
  11. Klausner AP, Streng T, Na YG, Raju J, Batts TW, Tuttle JB, Andersson KE, Steers WD. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat. Auton Neurosci. 2005 Dec 30; 123(1-2):26-35.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.